written on 03.03.2014
Argentina: pharma sales by therapeutic area, 2012
Latest Report
LatAm / Bayer Bets Big in Costa Rica/Argentina; Mexico Drug Approvals Slow; Pfizer’s Aggressive Supply Deal Tactics
The latest from the healthcare industry in Latin America, including an alarming OECD report about the decline of well-being in the region due to Covid-19, Bayer’s USD 350 million investment…
LatAm / Big Indian Investment; Argentina's COVID-19 Woes; Cannabis ‘Green Rush’ in Mexico
The latest from healthcare and the life sciences in Latin America, including the most recent wave of Indian pharma investment; Argentina’s ongoing struggle with COVID-19; issues around unchecked use of…
COVID-19 in Latin America / News Roundup September 2020
The latest from the fight against COVID-19 in Latin America, including J&J’s vaccine trials, issues surrounding Chinese-made diagnostic tests, Colombia’s vaccine manufacturing capacity, and potential compulsory licensing in Brazil. …